Month: October 2019

Microsoft’s Azure cloud business showed slower quarterly growth even as the software maker topped estimates for profit and revenue, indicating that the company may be facing intense competition in its fastest-growing business. Since Chief Executive Satya Nadella took over in 2014, Microsoft has been diversifying from its Windows operating system software, and has focused on its cloud services, in which customers move their computing work to data centers managed by Microsoft. …read more […]

PayPal shares up after the company beat estimates across the board. Yahoo Finance’s The Final Round take a deeper look into the company’s earnings report. …read more […]

You may have never heard of B&G Foods (NYSE: BGS), but there’s a good chance you’ve got some of the company’s products in your kitchen right now.
B&G Foods produces name-brand food products, such as Green Giant frozen vegetables, Mrs. Dash spices, Ortega tortillas and taco shells, SnackWell’s cookies, and many more snacks sold in grocery stores across the country.
The company buys struggling food brands and revamps them so that their sales resume growth.
Today it sports a hefty 11.67% dividend yield.
So will this double-digit yield have investors echoing the Green Giant’s signature “Ho, ho, ho”? Or will they say “No, no, …read more […]

Tech giant Microsoft is out with its fiscal first-quarter results. Yahoo Finance’s Heidi Chung breaks it down to Jen Rodgers, Myles Udland, and Akiko Fujita. …read more […]

Microsoft reported its Q1 2020 earnings on Wednesday, beating on both revenue and earnings per share. …read more […]

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to… …read more […]

NEW YORK/BOSTON (Reuters) – Teva Pharmaceutical Industries Ltd’s proposed $23 billion (£17.85 billion) drug giveaway to settle thousands of U.S. opioid lawsuits will likely cost the company a fraction of that figure due to how it has valued those medicines, according to a Reuters review of pricing data and industry analysts. When Teva announced the value of the donated medicine – a generic version of opioid addiction treatment Suboxone – it based the figure on the drug’s list price, which does not account for significant discounts routinely provided by the drugmaker. If based on the estimated cost …read more […]

There’s no doubt that money can be made by owning shares of unprofitable businesses. For example, although… …read more […]

The parent company of Snapchat reported earnings that beat expectations, but provided a weak outlook. Yahoo Finance’s Brian Cheung, Ines Ferre and Heidi Chung join Akiko Fujita on The Ticker to discuss. …read more […]